More articles from Clinical Investigations (Human)

You have access
PSMA PET Tumor–to–Salivary Gland Ratio to Predict Response to [¹⁷⁷Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective Study
Masatoshi Hotta, Andrei Gafita, Vishnu Murthy, Matthias R. Benz, Ida Sonni, Irene A. Burger, Matthias Eiber, Louise Emmett, Andrea Farolfi, Wolfgang P. Fendler, Manuel M. Weber, Michael S. Hofman, Thomas A. Hope, Clemens Kratochwil, Johannes Czernin and Jeremie Calais

Journal of Nuclear Medicine March 30, 2023, jnumed.122.265242; DOI: https://doi.org/10.2967/jnumed.122.265242
Open Access
PSMA-GCK01 - A Generator-Based ^99mTc-/¹⁸⁸Re-Theranostic Ligand for the Prostate-Specific Membrane Antigen
Jens Cardinale, Frederik L. Giesel, Christina Wensky, Hendrik G. Rathke, Uwe Haberkorn and Clemens Kratochwil

Journal of Nuclear Medicine February 9, 2023, jnumed.122.264944; DOI: https://doi.org/10.2967/jnumed.122.264944
You have access
The added value of ¹⁸F-FDG PET/CT compared to ⁶⁸Ga-PSMA PET/CT in patients with castration-resistant prostate cancer
Ruohua Chen, Yining Wang, Yinjie Zhu, Yiping Shi, Lian Xu, Gang Huang and Jianjun Liu

Journal of Nuclear Medicine April 23, 2021, jnumed.121.262250; DOI: https://doi.org/10.2967/jnumed.121.262250

Main menu